Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» The Best- And Worst-Performing Biotech Stocks,Jan. 3 to Jan. 10
The Best- And Worst-Performing Biotech Stocks,Jan. 3 to Jan. 10
The Best- And Worst-Performing Biotech Stocks,Jan. 3 to Jan. 10
Submitted by
admin
on January 11, 2014 - 10:13am
Source:
Forbes
News Tags:
Neurocrine
Intercept Pharma
Epizyme
Sangamo BioSciences
OncoMed
Zogenix
Macrogenics
Intrexon
Pharmacyclics
Galena Biopharma
Headline:
The Best- And Worst-Performing Biotech Stocks,Jan. 3 to Jan. 10
Do Not Allow Advertisers to Use My Personal information